To The Editor:
We were moved to read the personal narratives you shared in your May 12 story, 3 years into the pandemic, Vermonters are still getting — and struggling with — long Covid. The chronic challenges of conditions like Long Covid and Lyme Disease are too common in our state.
However, we were disappointed that no mention was made of Hyperbaric Oxygen Therapy (HBOT) as a therapeutic modality for addressing these issues. HBOT – the therapeutic use of oxygen at higher than atmospheric pressure – isn’t well known in the US, but is widely used worldwide to treat everything from Multiple Sclerosis to Autism to Bell’s Palsy to Stroke and Rheumatoid Arthritis.
HBOT is a potent anti-inflammatory, and a viable option for treating patients with Long Covid. Here at Hyperbaric Vermont, we’ve had a great deal of success helping Long Covid patients recover, and scientific studies from the UK and Israel support our experience.
We are dedicated to hope, healing, and recovery for all Vermonters, and it would be a shame if folks who are suffering remain in the dark about a simple, effective treatment which can help them regain their health.
Sincerely,
Kathryn Blume, Managing Director